Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
Identifieur interne : 001E36 ( PubMed/Curation ); précédent : 001E35; suivant : 001E37Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
Auteurs : K G Vaishnav ; H S Desai ; P K Srivastava ; P T Joshi ; G. Kurian ; H G Thakor ; A C DhariwalSource :
- The Journal of communicable diseases [ 0019-5138 ] ; 2012.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Enfant, Enfant d'âge préscolaire, Femelle, Filaricides (administration et posologie), Filaricides (effets indésirables), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Inde (épidémiologie), Jeune adulte, Maladies endémiques (), Mâle, Nourrisson, Services de médecine préventive, Surveillance sentinelle, Éradication de maladie ().
- MESH :
- administration et posologie : Filaricides.
- effets indésirables : Filaricides.
- traitement médicamenteux : Filariose lymphatique.
- épidémiologie : Filariose lymphatique, Inde.
- Adolescent, Adulte, Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique, Humains, Jeune adulte, Maladies endémiques, Mâle, Nourrisson, Services de médecine préventive, Surveillance sentinelle, Éradication de maladie.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, Disease Eradication (methods), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Endemic Diseases (prevention & control), Female, Filaricides (administration & dosage), Filaricides (adverse effects), Humans, India (epidemiology), Infant, Male, Preventive Health Services, Sentinel Surveillance, Young Adult.
- MESH :
- chemical , administration & dosage : Filaricides.
- chemical , adverse effects : Filaricides.
- geographic , epidemiology : India.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- methods : Disease Eradication.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases.
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Preventive Health Services, Sentinel Surveillance, Young Adult.
Abstract
Lymphatic filariasis (LF) is one of the major public health problems in some of the endemic districts in India including Surat city of Gujarat province. Historical data reveals that in 1960s, Surat city had infection rate of about 23% and infectivity rate of 1.6%. Since then, Surat city has been reporting the cases of Lymphoedema and hydrocele. Filaria Control Unit was established under National Filaria Control Programme to detect and provide treatment to the cases. Based on the reports of NFCP, Surat City has been considered as LF endemic. During 2004, the country launched campaign of Elimination of Lymphatic Filariasis through Mass Drug Administration (MDA) with annual single dose of 6 mg/kg body weight of DEC tablets in all LF endemic districts including Surat city. Four rounds of MDA (2004-2007) had shown 41% reduction in mf rate, with drastic reduction in infection rate of 88% and 100% in infectivity rate. Serious adverse effect (SAE) after 4th round of MDA was insignificant (< 0.5%) during 2007. An assessment by surveying 5058 people in different parts of Surat city revealed the drug distribution coverage of more than 95% but actual drug compliance between 70-90%. Analysis of the data revealed that though the overall Microfilaria rate has been reduced due to MDA, higher Microfilaria rate was noticed in North zone of city where the migrant populations influx is higher. The observation and analysis of the data in Surat city towards elimination of Lymphatic filariasis has been discussed in this paper.
PubMed: 25145075
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E36
Links to Exploration step
pubmed:25145075Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.</title>
<author><name sortKey="Vaishnav, K G" sort="Vaishnav, K G" uniqKey="Vaishnav K" first="K G" last="Vaishnav">K G Vaishnav</name>
</author>
<author><name sortKey="Desai, H S" sort="Desai, H S" uniqKey="Desai H" first="H S" last="Desai">H S Desai</name>
</author>
<author><name sortKey="Srivastava, P K" sort="Srivastava, P K" uniqKey="Srivastava P" first="P K" last="Srivastava">P K Srivastava</name>
</author>
<author><name sortKey="Joshi, P T" sort="Joshi, P T" uniqKey="Joshi P" first="P T" last="Joshi">P T Joshi</name>
</author>
<author><name sortKey="Kurian, G" sort="Kurian, G" uniqKey="Kurian G" first="G" last="Kurian">G. Kurian</name>
</author>
<author><name sortKey="Thakor, H G" sort="Thakor, H G" uniqKey="Thakor H" first="H G" last="Thakor">H G Thakor</name>
</author>
<author><name sortKey="Dhariwal, A C" sort="Dhariwal, A C" uniqKey="Dhariwal A" first="A C" last="Dhariwal">A C Dhariwal</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:25145075</idno>
<idno type="pmid">25145075</idno>
<idno type="wicri:Area/PubMed/Corpus">001E36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E36</idno>
<idno type="wicri:Area/PubMed/Curation">001E36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E36</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.</title>
<author><name sortKey="Vaishnav, K G" sort="Vaishnav, K G" uniqKey="Vaishnav K" first="K G" last="Vaishnav">K G Vaishnav</name>
</author>
<author><name sortKey="Desai, H S" sort="Desai, H S" uniqKey="Desai H" first="H S" last="Desai">H S Desai</name>
</author>
<author><name sortKey="Srivastava, P K" sort="Srivastava, P K" uniqKey="Srivastava P" first="P K" last="Srivastava">P K Srivastava</name>
</author>
<author><name sortKey="Joshi, P T" sort="Joshi, P T" uniqKey="Joshi P" first="P T" last="Joshi">P T Joshi</name>
</author>
<author><name sortKey="Kurian, G" sort="Kurian, G" uniqKey="Kurian G" first="G" last="Kurian">G. Kurian</name>
</author>
<author><name sortKey="Thakor, H G" sort="Thakor, H G" uniqKey="Thakor H" first="H G" last="Thakor">H G Thakor</name>
</author>
<author><name sortKey="Dhariwal, A C" sort="Dhariwal, A C" uniqKey="Dhariwal A" first="A C" last="Dhariwal">A C Dhariwal</name>
</author>
</analytic>
<series><title level="j">The Journal of communicable diseases</title>
<idno type="ISSN">0019-5138</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Disease Eradication (methods)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Endemic Diseases (prevention & control)</term>
<term>Female</term>
<term>Filaricides (administration & dosage)</term>
<term>Filaricides (adverse effects)</term>
<term>Humans</term>
<term>India (epidemiology)</term>
<term>Infant</term>
<term>Male</term>
<term>Preventive Health Services</term>
<term>Sentinel Surveillance</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filaricides (administration et posologie)</term>
<term>Filaricides (effets indésirables)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Inde (épidémiologie)</term>
<term>Jeune adulte</term>
<term>Maladies endémiques ()</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Services de médecine préventive</term>
<term>Surveillance sentinelle</term>
<term>Éradication de maladie ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Disease Eradication</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Endemic Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Inde</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Preventive Health Services</term>
<term>Sentinel Surveillance</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Maladies endémiques</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Services de médecine préventive</term>
<term>Surveillance sentinelle</term>
<term>Éradication de maladie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) is one of the major public health problems in some of the endemic districts in India including Surat city of Gujarat province. Historical data reveals that in 1960s, Surat city had infection rate of about 23% and infectivity rate of 1.6%. Since then, Surat city has been reporting the cases of Lymphoedema and hydrocele. Filaria Control Unit was established under National Filaria Control Programme to detect and provide treatment to the cases. Based on the reports of NFCP, Surat City has been considered as LF endemic. During 2004, the country launched campaign of Elimination of Lymphatic Filariasis through Mass Drug Administration (MDA) with annual single dose of 6 mg/kg body weight of DEC tablets in all LF endemic districts including Surat city. Four rounds of MDA (2004-2007) had shown 41% reduction in mf rate, with drastic reduction in infection rate of 88% and 100% in infectivity rate. Serious adverse effect (SAE) after 4th round of MDA was insignificant (< 0.5%) during 2007. An assessment by surveying 5058 people in different parts of Surat city revealed the drug distribution coverage of more than 95% but actual drug compliance between 70-90%. Analysis of the data revealed that though the overall Microfilaria rate has been reduced due to MDA, higher Microfilaria rate was noticed in North zone of city where the migrant populations influx is higher. The observation and analysis of the data in Surat city towards elimination of Lymphatic filariasis has been discussed in this paper.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25145075</PMID>
<DateCreated><Year>2014</Year>
<Month>08</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>08</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-5138</ISSN>
<JournalIssue CitedMedium="Print"><Volume>44</Volume>
<Issue>4</Issue>
<PubDate><Year>2012</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of communicable diseases</Title>
<ISOAbbreviation>J Commun Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.</ArticleTitle>
<Pagination><MedlinePgn>251-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Lymphatic filariasis (LF) is one of the major public health problems in some of the endemic districts in India including Surat city of Gujarat province. Historical data reveals that in 1960s, Surat city had infection rate of about 23% and infectivity rate of 1.6%. Since then, Surat city has been reporting the cases of Lymphoedema and hydrocele. Filaria Control Unit was established under National Filaria Control Programme to detect and provide treatment to the cases. Based on the reports of NFCP, Surat City has been considered as LF endemic. During 2004, the country launched campaign of Elimination of Lymphatic Filariasis through Mass Drug Administration (MDA) with annual single dose of 6 mg/kg body weight of DEC tablets in all LF endemic districts including Surat city. Four rounds of MDA (2004-2007) had shown 41% reduction in mf rate, with drastic reduction in infection rate of 88% and 100% in infectivity rate. Serious adverse effect (SAE) after 4th round of MDA was insignificant (< 0.5%) during 2007. An assessment by surveying 5058 people in different parts of Surat city revealed the drug distribution coverage of more than 95% but actual drug compliance between 70-90%. Analysis of the data revealed that though the overall Microfilaria rate has been reduced due to MDA, higher Microfilaria rate was noticed in North zone of city where the migrant populations influx is higher. The observation and analysis of the data in Surat city towards elimination of Lymphatic filariasis has been discussed in this paper.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaishnav</LastName>
<ForeName>K G</ForeName>
<Initials>KG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Desai</LastName>
<ForeName>H S</ForeName>
<Initials>HS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Srivastava</LastName>
<ForeName>P K</ForeName>
<Initials>PK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Joshi</LastName>
<ForeName>P T</ForeName>
<Initials>PT</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kurian</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Thakor</LastName>
<ForeName>H G</ForeName>
<Initials>HG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dhariwal</LastName>
<ForeName>A C</ForeName>
<Initials>AC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>J Commun Dis</MedlineTA>
<NlmUniqueID>0261652</NlmUniqueID>
<ISSNLinking>0019-5138</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011314" MajorTopicYN="N">Preventive Health Services</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018571" MajorTopicYN="N">Sentinel Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>12</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25145075</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001E36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25145075 |texte= Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25145075" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |